WASHINGTON, Jan. 4, 2024
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)
today announced that the company will participate in the J.P.
Morgan Healthcare Conference in San
Francisco, California on Tuesday,
January 9, 2024. A corporate presentation is scheduled
for 9:45 a.m. Pacific Time
(12:45 p.m. Eastern Time).
The corporate presentation given at the J.P. Morgan Healthcare
Conference may be accessed live on Vanda's corporate website,
www.vandapharma.com. Investors should click on the Investors tab
and follow the link under Recent Events. Investors are advised to
go to the conference website at least 15 minutes early to register,
download, and install any necessary software or presentations. A
link to the archived conference will be available on Vanda's
website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jp-morgan-healthcare-conference-302026715.html
SOURCE Vanda Pharmaceuticals Inc.